U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2007
239
Substance Class Protein
Created
by admin
on Wed Apr 02 01:54:19 GMT 2025
Edited
by admin
on Wed Apr 02 01:54:19 GMT 2025
Protein Type GROWTH FACTOR
Protein Sub Type PEGYLATED PROTEIN|ERYTHROPOIETIN
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
LR3UXN0193
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
DASH   EMA EPAR   MART.   VANDF   WHO-DD  
Common Name English
PEGZEREPOETIN ALFA
Preferred Name English
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA [VANDF]
Common Name English
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA [PURPLE BOOK CDER]
Common Name English
R744
Code English
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA [MART.]
Common Name English
R-744
Code English
MIRCERA
Brand Name English
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA [EMA EPAR]
Common Name English
CERA
Common Name English
Methoxy polyethylene glycol-epoetin beta [WHO-DD]
Common Name English
1-165-ERYTHROPOIETIN (HUMAN), MONAMIDE WITH .ALPHA.-(3-CARBOXYPROPYL)-.OMEGA.-METHOXYPOLY(OXY-1,2-ETHANEDIYL)
Common Name English
Classification Tree Code System Code
NDF-RT N0000008193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000008193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000008193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
WHO-VATC QB03XA03
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000008193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
EMA ASSESSMENT REPORTS MIRCERA (AUTHORIZED: ANEMIA)
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000175665
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
EMA ASSESSMENT REPORTS MIRCERA (AUTHORIZED: KIDNEY FAILURE, CHRONIC)
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000008193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
NDF-RT N0000009319
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
WHO-ATC B03XA03
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
Code System Code Type Description
DAILYMED
LR3UXN0193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
CAS
677324-53-7
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
WIKIPEDIA
Methoxy polyethylene glycol-epoetin beta
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
FDA UNII
LR3UXN0193
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
SMS_ID
100000089843
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
EVMPD
SUB26425
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
NCI_THESAURUS
C87201
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
DRUG CENTRAL
5165
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
DRUG BANK
DB09107
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
CHEBI
16526
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
HSDB
8219
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
MESH
C508420
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL3707314
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY
RXCUI
729596
Created by admin on Wed Apr 02 01:54:19 GMT 2025 , Edited by admin on Wed Apr 02 01:54:19 GMT 2025
PRIMARY RxNorm
From To
1_7 1_161
1_29 1_33
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_24
N 1_38
N 1_83
O 1_126
Related Record Type Details
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC K Amount: UNSPECIFIED SUBSTANCE
5ea59f01
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:WEIGHT AVERAGE CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966